Related Experiment Video
Updated: Mar 1, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Polypharmacy in Cardiovascular Medicine: Problems and Promises!
Mehran Abolbashari1, Tracy E Macaulay2, Thomas F Whayne2
1Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, TX, United States.
Polypharmacy, the use of multiple medications, increases risks for older adults, especially with cardiovascular diseases. Strategies are needed to manage complex drug regimens and prevent adverse drug events.
Area of Science:
- Geriatric Medicine
- Cardiology
- Pharmacology
Background:
- Polypharmacy is prevalent in older adults managing multiple comorbidities.
- It increases risks of adverse drug reactions and interactions.
- Clinicians hesitate to adjust complex medication regimens, often failing to stop non-beneficial drugs.
Purpose of the Study:
- To review challenges associated with polypharmacy.
- To focus on polypharmacy issues within cardiovascular disease management.
Main Methods:
- Literature review on polypharmacy and cardiovascular diseases.
- Discussion of current challenges and proposed solutions like the polypill.
Main Results:
- Increasing cardiovascular disease prevalence, driven by obesity and diabetes, necessitates complex medication management.
- Guidelines recommend multiple drugs, but this can lead to adverse outcomes.
- The polypill is a potential strategy to reduce medication burden and improve cardiovascular prevention.
Conclusions:
- Polypharmacy presents significant challenges in modern medicine.
- Effective management strategies are crucial, particularly for cardiovascular diseases in older patients.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Drug Therapy
Antianxiety Medications
